Join to View Full Profile
2520 5th St NColumbus, MS 39705
Phone+1 662-244-4673
Fax+1 662-244-2906
Dr. Whitecar is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- John P Whitecar Jr., MD, FACP, FACMQ is an Oncology specialist based in Columbus, MS. He completed his education and training at the University of Minnesota, including a fellowship in Hematology and Medical Oncology and several residencies in Internal Medicine. Additionally, he is a graduate of the Sidney Kimmel Medical College at Thomas Jefferson University. Dr. Whitecar has expertise in various areas including infection-induced thrombocytopenia, hairy cell leukemia, acute leukemias, coagulopathies among others. He has published multiple research papers in well-known medical journals, some which have been highly cited. He also received the CMS Meaningful Use Stage 1 Certification from MOSAIQ EMR process in 2013.
Education & Training
University of Texas Health Science Center at Houston/M D Anderson Cancer CenterFellowship, Hematology and Medical Oncology, 1968 - 1970
University of MinnesotaResidency, Internal Medicine, 1967 - 1968- University of MinnesotaFellowship, Hematology and Medical Oncology, 1966 - 1967
- University of MinnesotaResidency, Internal Medicine, 1965 - 1966
- University of MinnesotaInternship, Internal Medicine, 1964 - 1965
Certifications & Licensure
TX State Medical License 1969 - 2027
MS State Medical License 1997 - 2026
TN State Medical License 1995 - 2013
MN State Medical License 1967 - 1975
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification MOSAIQ, Elekta - IMPAC Medical Systems, Inc., 2013
- CMS Meaningful Use Stage 1 Certification MOSAIQ EMR, Elekta, 2013
Publications & Presentations
PubMed
- 4 citationsA study of intermittent alternating drug program reinduction therapy on the frequency and duration of response in adult acute leukemiaKenneth B. McCredie, Emil J. Freireich, Gerald P. Bodey, M. A. Burgess, John P. Whitecar
Medical and Pediatric Oncology. 1976-01-01 - 2 citationsClinical studies of β‐thioguanine deoxyriboside alone and in combination with arabinosyl cytosineGerald P. Bodey, Kenneth B. McCredie, John P. Whitecar, Emil J. Freireich
Medical and Pediatric Oncology. 1976-01-01 - 62 citationsPomp combination chemotherapy of adult acute leukemia.Victorio Rodriguez, Jacqueline S. Hart, Emil J. Freireich, Gerald P. Bodey, Kenneth B. McCredie
Cancer. 1973-07-01
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
